Qiuqiong Tang

This inventor holds 8 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Ascentage Pharma (Suzhou) Co., Ltd., Ascentage Pharma Group Corp Limited. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qiuqiong Tang. Retrieved from https://idiyas.com/inventor/qiuqiong-tang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

8 out of 31

Ascentage Pharma (Suzhou) Co., Ltd.

patents

5 out of 29

Ascentage Pharma Group Corp Limited

patents

where one patent can have more than one assignee

Years Active: 2022-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12514863 - Pharmaceutical combination and use thereof (2026-01-06),

2. 12370197 - Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and use thereof in the prevention and/or treatment of diseases (2025-07-29),

3. 12268665 - Combination of immunotherapies with MDM2 inhibitors (2025-04-08),

4. 12233047 - Pharmaceutical combination and use thereof (2025-02-25),

5. 12194024 - Pharmaceutical composition of MDM2 inhibitor and use thereof for preventing and/or treating disease (2025-01-14),

6. 12186304 - Method for treating cancer by combination of IAP inhibitor and modulator of immune checkpoint molecule (2025-01-07),

7. 11478469 - Combination product of BCL-2 inhibitor and MDM2 inhibitor and use thereof in the prevention and/or treatment of diseases (2022-10-25),

8. 11452716 - Pharmaceutical composition and use thereof (2022-09-27),

Title: Qiuqiong Tang: Innovator at Ascentage Pharma Co., Ltd.

Introduction

Qiuqiong Tang is a prominent figure in the pharmaceutical industry, currently contributing to the innovative work at Ascentage Pharma Co., Ltd. Based in China, he is part of a team that strives to develop novel therapies for the treatment of cancer and age-related diseases.

Latest Patents

As of now, Qiuqiong Tang holds no patents, which may reflect his recent engagement in the field and the collaborative nature of his work at Ascentage Pharma Co., Ltd.

Career Highlights

Although Qiuqiong Tang's patent portfolio is yet to be established, his career at Ascentage Pharma Co., Ltd. showcases his commitment to pharmaceutical innovations. His work contributes to the advancement of key projects within the company, helping to foster groundbreaking research and development efforts in the health sector.

Collaborations

Throughout his career, Qiuqiong Tang has collaborated with notable coworkers such as Dajun Yang and Yifan Zhai. These partnerships have likely enhanced the breadth of knowledge and expertise within the team, aiding Ascentage Pharma in its mission to bring impactful therapies to market.

Conclusion

Qiuqiong Tang exemplifies the spirit of innovation within the pharmaceutical industry through his efforts at Ascentage Pharma Co., Ltd. While he does not yet hold patents, his professional journey is marked by valuable collaborations and a dedication to improving health outcomes. The future may hold significant developments for him as he continues to contribute to important research and innovations.

Profile summary based on public USPTO records.